Black patients more likely to be excluded from pancreatic cancer

$ 16.99

4.6
(587)
In stock
Description

Fox Chase researchers study PTEN mutations in CRC to enhance clinical targeting - The Cancer Letter

Impact of Ethnicity on Outcome in Pancreatic Carcinoma

Adipose tissue and skeletal muscle wasting precede clinical diagnosis of pancreatic cancer

Black patients more likely to be excluded from pancreatic

Cancer disruptors: When Bernie Fisher refused to grovel - The Cancer Letter

NCI trials for April 2022 - The Cancer Letter

Differentiation of chronic mass-forming pancreatitis from pancreatic d

Trends in treatment patterns and survival outcomes in pancreatic cancer: A nationwide population-based study in Korea - ScienceDirect

Bassel El-Rayes named deputy director of O'Neal Comprehensive Cancer Center - The Cancer Letter

Nab-paclitaxel plus gemcitabine as first-line treatment for advanced pancreatic cancer: a systematic review and meta-analysis

AACI Update